Results 181 to 190 of about 63,667 (225)

Review Article: Renal Safety Profiles of Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, and Entecavir for the Treatment of Chronic Hepatitis B Infection-General and Special Populations. [PDF]

Aliment Pharmacol Ther
Mak LY, Hu TH, Yap DYH.
europepmc   +1 more source

Healthcare Resource Consumption and Related Costs of People Living with HIV and Antiviral Treatment: A Retrospective Observational Study in Italy. [PDF]

Diseases
Degli Esposti L, Mazzoni S, Cappuccilli M, Maggiolo F, Caputo SL, Nozza S, Taramasso L, Marra A, Pittorru M.   +8 more
europepmc   +1 more source

Tenofovir vs. entecavir in chronic hepatitis B: A retrospective cohort study of hepatocellular carcinoma risk in a tertiary hospital in southern Brazil. [PDF]

Braz J Infect Dis
Stamm AN, Tovo CV, Noal A, Silva CU, Pizzi J, Fonseca PM, Kliemann DA.   +6 more
europepmc   +1 more source

Kidney Dysfunction In Young People Living With HIV On Dolutegravir-Based Regimens In Kampala, Uganda

Nasuuna EM, Hoffman R, Kalyesubula R, Chikwari CD, Weiss HA.   +4 more
europepmc   +1 more source

Evidence for a relationship between concentrations of nucleos/tide analogue agents and treatment outcome in chronic hepatitis B infection: A systematic review

Sukali G, Anderson M, Mohammed KS, Biggs P, Delphin M, Redmond JM, Maponga T, Govender K, Amponsah SK, Alffenaar J, Waitt C, Iwuji C, Matthews PC.   +12 more
europepmc   +1 more source